InSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend

Bulletin Express

08/11

InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.

The session will also cover other routine corporate matters. The board currently comprises two executive directors—Chairman and CEO Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren—one non-executive director, Dr. Chuen Yan Leung, and three independent non-executive directors: Dr. Jingsong Wang, Dr. Denitsa Milanova, and Mr. Roman Kyrychynskyi.

The announcement was released in Hong Kong on 11 August 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1100244765"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100244765\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100244765?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100244765","market":"us","top_or_hot":-1,"title":"InSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend","media":"Bulletin Express","content":"<p>InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.</p>\n<p>The session will also cover other routine corporate matters. The board currently comprises two executive directors—Chairman and CEO Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren—one non-executive director, Dr. Chuen Yan Leung, and three independent non-executive directors: Dr. Jingsong Wang, Dr. Denitsa Milanova, and Mr. Roman Kyrychynskyi.</p>\n<p>The announcement was released in Hong Kong on 11 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInSilico Schedules 26 August Board Meeting to Approve H1-2026 Results and Consider Interim Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-11 17:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>InSilico Medicine Cayman TopCo (abbreviated as “InSilico”) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.</p>\n<p>The session will also cover other routine corporate matters. The board currently comprises two executive directors—Chairman and CEO Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren—one non-executive director, Dr. Chuen Yan Leung, and three independent non-executive directors: Dr. Jingsong Wang, Dr. Denitsa Milanova, and Mr. Roman Kyrychynskyi.</p>\n<p>The announcement was released in Hong Kong on 11 August 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1100244765","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100244765","pubTimestamp":1786441561,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InSilico Medicine Cayman TopCo (abbreviated as 「InSilico」) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"InSilico 计划于 8 月 26 日召开董事会会议，批准 H1-2026 业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"InSilico Medicine Cayman TopCo (abbreviated as 「InSilico」) has set 26 August 2026 as the date for its upcoming board meeting. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.\nThe session will also cover other routine corporate matters. The board currently comprises two executive directors—Chairman and CEO Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren—one non-executive director, Dr. Chuen Yan Leung, and three independent non-executive directors: Dr. Jingsong Wang, Dr. Denitsa Milanova, and Mr. Roman Kyrychynskyi.\nThe announcement was released in Hong Kong on 11 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}